DK110879A - Ornithin-og argininsalte af forgrenede keto-syrer fremgangsmaade til fremstilling deraf samt deres anvendelse - Google Patents

Ornithin-og argininsalte af forgrenede keto-syrer fremgangsmaade til fremstilling deraf samt deres anvendelse

Info

Publication number
DK110879A
DK110879A DK110879A DK110879A DK110879A DK 110879 A DK110879 A DK 110879A DK 110879 A DK110879 A DK 110879A DK 110879 A DK110879 A DK 110879A DK 110879 A DK110879 A DK 110879A
Authority
DK
Denmark
Prior art keywords
ornithin
acides
procedures
preparation
arginine salts
Prior art date
Application number
DK110879A
Other languages
English (en)
Other versions
DK153542C (da
DK153542B (da
Inventor
M K Walser
Original Assignee
Univ Johns Hopkins
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Johns Hopkins filed Critical Univ Johns Hopkins
Publication of DK110879A publication Critical patent/DK110879A/da
Publication of DK153542B publication Critical patent/DK153542B/da
Application granted granted Critical
Publication of DK153542C publication Critical patent/DK153542C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/185—Saturated compounds having only one carboxyl group and containing keto groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK110879A 1978-03-17 1979-03-16 Analogifremgangsmaade til fremstilling af ornithin- eller argininsalte af forgrenede alfa-keto-syrer DK153542C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/887,570 US4228099A (en) 1978-03-17 1978-03-17 Ornithine and arginine salts of branched chain keto acids and uses in treatment of hepatic and renal disorders
US88757078 1978-03-17

Publications (3)

Publication Number Publication Date
DK110879A true DK110879A (da) 1979-09-18
DK153542B DK153542B (da) 1988-07-25
DK153542C DK153542C (da) 1988-12-05

Family

ID=25391422

Family Applications (1)

Application Number Title Priority Date Filing Date
DK110879A DK153542C (da) 1978-03-17 1979-03-16 Analogifremgangsmaade til fremstilling af ornithin- eller argininsalte af forgrenede alfa-keto-syrer

Country Status (17)

Country Link
US (1) US4228099A (da)
JP (1) JPS5838421B2 (da)
AU (1) AU517505B2 (da)
BE (1) BE874900A (da)
CA (1) CA1115729A (da)
DE (1) DE2910221A1 (da)
DK (1) DK153542C (da)
ES (1) ES478710A1 (da)
FI (1) FI72118C (da)
FR (1) FR2419723A1 (da)
GB (1) GB2017094B (da)
IE (1) IE48336B1 (da)
IT (1) IT1202904B (da)
LU (1) LU81057A1 (da)
NL (1) NL7902136A (da)
NO (1) NO151119C (da)
SE (1) SE446724B (da)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4296127A (en) * 1979-04-18 1981-10-20 The Johns Hopkins University Mixed salts of essential or semi-essential amino acids and nitrogen-free analogs thereof
DE3438455A1 (de) * 1984-10-19 1986-06-26 Institut Dr. Ziegler, Bettingen L-lysin- und l-histidinpyruvat
US4677121A (en) * 1985-01-22 1987-06-30 The Johns Hopkins University Method of inhibiting muscle protein degradation
US4752619A (en) * 1985-12-23 1988-06-21 The Johns Hopkins University Nutritional supplement for treatment of uremia
US4744990A (en) * 1986-09-25 1988-05-17 W. R. Grace & Co. Hydantoins as animal food supplements
US4871552A (en) * 1986-09-25 1989-10-03 W. R. Grace & Co.-Conn. Hydantoins as animal food supplements
US5639731A (en) * 1987-05-22 1997-06-17 Pripps Bryggerier Ab Amino acids for the preparation of a beverage
FR2615734B1 (fr) * 1987-05-27 1989-12-01 Synthelabo Compositions pharmaceutiques contenant un melange de sels de cetoacides et d'amino-acides utiles pour le traitement de l'uremie
FR2618331B1 (fr) * 1987-07-23 1991-10-04 Synthelabo Compositions pharmaceutiques utiles pour le traitement de l'uremie
AT393080B (de) * 1988-11-25 1991-08-12 Lubec Gert Pharmazeutische verwendung von arginin (salzen)
AT393079B (de) * 1989-03-06 1991-08-12 Lubec Gert Pharmazeutische verwendung von agmatin
SE462463B (sv) * 1988-12-02 1990-07-02 Decken Alexandra V D Livs- och fodermedel innehaallande ketosyror
JP2522034B2 (ja) * 1988-12-27 1996-08-07 味の素株式会社 α−ケト酸・アミノ酸塩化合物及びその製造方法
US5210098A (en) * 1990-09-21 1993-05-11 Regents Of The University Of Minnesota Use of pyruvate to treat acute renal failure
US5234696A (en) * 1991-12-27 1993-08-10 Abbott Laboratories Method of producing tablets, tablets produced thereby, and method of treatment using same
CA2177380A1 (fr) 1994-10-07 1996-04-18 Godefridus Van Den Ouweland Compositions aromatisantes et procede d'aromatisation
US5591736A (en) * 1995-07-03 1997-01-07 The Johns Hopkins University Method of retarding the progression of chronic renal failure
WO2002081020A2 (en) * 2001-04-04 2002-10-17 Critical Therapeutics, Inc. Method for preventing acute renal failure
WO2006051940A1 (ja) * 2004-11-15 2006-05-18 Kyowa Hakko Kogyo Co., Ltd. Ｌ－オルニチン結晶およびその製造方法
DK2319581T3 (da) * 2004-11-26 2015-06-01 Ucl Business Plc Sammensætninger omfattende ornithin og phenylacetat eller phenylbutyrat til behandling af hepatisk encephalopati
GB0426141D0 (en) * 2004-11-26 2004-12-29 Ucl Biomedica Plc Treatment
ES2652187T3 (es) 2009-04-03 2018-01-31 Ocera Therapeutics, Inc. Fenilacetato de l-ornitina y métodos para elaborar el mismo
SG176675A1 (en) 2009-06-08 2012-01-30 Ucl Business Plc Treatment of portal hypertension and restoration of liver function using l-ornithine phenylacetate
KR101888215B1 (ko) 2010-10-06 2018-09-20 오세라 테라퓨틱스, 아이엔씨. L-오르니틴 페닐아세테이트의 제조 방법
NZ732632A (en) 2014-11-24 2021-07-30 Ucl Business Ltd Treatment of diseases associated with hepatic stellate cell activation using ammonia-lowering therapies
US10835506B2 (en) 2015-08-18 2020-11-17 Ocera Therapeutics, Inc. Treatment and prevention of muscle loss using L-ornithine in combination with at least one of phenylacetate and phenylbutyrate
CN106674057A (zh) * 2015-11-09 2017-05-17 江西乐维生物药业有限公司 L-精氨酸a-酮基异己酸盐的制备方法
US11219611B2 (en) 2015-11-13 2022-01-11 Ocera Therapeutics, Inc. Formulations of L-ornithine phenylacetate
WO2017090007A1 (en) * 2015-11-29 2017-06-01 Rao M Surya Compositions and methods for the treatment of urea cycle disorders and hepatic diseases
WO2018208677A1 (en) 2017-05-11 2018-11-15 Ocera Therapeutics, Inc. Processes of making l-ornithine phenylacetate
EP3716966A4 (en) 2017-11-29 2021-08-18 Hull, Edgar, L., Jr. ALPHA-KETOACID COMPOSITIONS FOR THE TREATMENT OF HYPOALBUMINEMIA
US11484579B2 (en) 2017-11-29 2022-11-01 Edgar L Hull Vitamins and alpha keto acid compositions for use in a treatment program for chronic kidney disease patients

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA814483A (en) * 1969-06-03 Abe Kyuji L-ornithine-l-aspartate
GB1034358A (en) 1963-05-01 1966-06-29 Chugai Pharmaceutical Co Ltd Body-protein-biosynthesis promoting composition
FR1432756A (fr) 1965-02-11 1966-03-25 D Opochimiotherapie Lab Pyruvates d'amino-acides et leur procédé de préparation
US3441650A (en) * 1965-07-23 1969-04-29 Lab Jacques Logeais Sa Therapy of ammonical intoxications by di-l-ornithine alpha-ketoglutarate
DE2335215B2 (de) * 1972-07-13 1979-04-05 The Johns Hopkins University, Baltimore, Md. (V.St.A.) Verwendung einer Mischung bei der Bekämpfung von zur Urämie führenden Nierenerkrankungen
US4100161A (en) * 1974-04-15 1978-07-11 The Johns Hopkins University Promotion of protein synthesis and suppression of urea formation in the body by keto analogs of essential amino acids
US3950529A (en) * 1975-02-03 1976-04-13 Massachusetts General Hospital Amino acid formulations for patients with liver disease and method of using same

Also Published As

Publication number Publication date
FI790901A (fi) 1979-09-18
NO790903L (no) 1979-09-18
FI72118B (fi) 1986-12-31
JPS5838421B2 (ja) 1983-08-23
JPS54163518A (en) 1979-12-26
GB2017094A (en) 1979-10-03
IT1202904B (it) 1989-02-15
FI72118C (fi) 1987-04-13
GB2017094B (en) 1982-07-07
SE7902401L (sv) 1979-10-16
DK153542C (da) 1988-12-05
US4228099A (en) 1980-10-14
FR2419723B1 (da) 1982-10-29
SE446724B (sv) 1986-10-06
ES478710A1 (es) 1980-01-16
DK153542B (da) 1988-07-25
CA1115729A (en) 1982-01-05
IE790993L (en) 1979-09-17
NO151119B (no) 1984-11-05
DE2910221A1 (de) 1979-09-20
BE874900A (fr) 1979-07-16
NL7902136A (nl) 1979-09-19
DE2910221C2 (da) 1988-04-28
IE48336B1 (en) 1984-12-12
AU517505B2 (en) 1981-08-06
LU81057A1 (fr) 1979-09-07
FR2419723A1 (fr) 1979-10-12
NO151119C (no) 1985-02-13
IT7921071A0 (it) 1979-03-16
AU4515479A (en) 1979-09-20

Similar Documents

Publication Publication Date Title
DK110879A (da) Ornithin-og argininsalte af forgrenede keto-syrer fremgangsmaade til fremstilling deraf samt deres anvendelse
DK46079A (da) Fremgangsmaade til fremstilling af alkylendiaminderivater
DK258479A (da) Spiro-oxazoldindioner fremgangsmaade til deres fremstilling samt deres anvendelse og mellemprodukter til udoevelse af fremgangsmaaden
DK157860C (da) Analogifremgangsmaade til fremstilling af benzylimidazolderivater samt farmaceutisk acceptable syreadditionssalte deraf
DK488078A (da) Quinazolin-derivater fremgangsmaade til deres fremstilling samt deres anvendelse
DK361878A (da) Fremgangsmaade til fremstilling af overtrukne praeparater
DK310779A (da) Fremgangsmaade til fremstilling af pyrimidinonderivater
DK18179A (da) 2-pyrrolidon-forbindelser og fremgangsmaade til deres fremstilling samt deres anvendelse til fremstilling af farmakologisk aktive forbindelser
DK95678A (da) Tetrahydrofuranetherderivater fremgangsmaade til fremtilling deraf samt deres anvendelse som herbicider
DK158836C (da) Analogifremgangsmaade til fremstilling af terapeutisk aktive anthraquinonderivater
DK410878A (da) Paa siliciumdioxid baserede skumbekaempende kompostitoner med forbedret stabilitet fremgangsmaade til deres fremstilling samt deres anvendelse
DK21777A (da) Fremgangsmade til fremstilling af oxigenerede n-aryl-diazacyler samt salte deraf
DK415379A (da) Fremgangsmaade til fremstilling af chromanolderivater
DK537677A (da) Propionsyrederivater samt fremgangsmaade til deres fremstilling
DK184579A (da) Estere af substituerede 8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepiner,fremgangsmaade til deres fremstilling samt deres anvendelse
DK69179A (da) Substituerede 2-phenylimino-imidazolidiner syreadditionssalte heraf samt fremgansmaade til fremstilling heraf
DK254780A (da) Alkoxybenzylpyridopyridiner fremgangsmaade til deres fremstilling samt deres anvendelse
DK391678A (da) Nitrogen-heterocycliske forbindelser fremgangsmaade til deres fremstilling samt deres anvendelse
DK333679A (da) Substituerede pyrazolderivater samt fremgangsmaade til deres fremstilling
DK160281C (da) Fremgangsmaade til fremstilling af steroid-s-thioesterderivater
DK62878A (da) Fremgangsmaade til fremstilling af benzoheterocyclylglyoxylsyrederivater samt salte deraf
DK159144C (da) Fremgangsmaade til fremstilling af optisk aktive aryloxyalkansyrederivater
DK348179A (da) Fremgangsmaade til fremstilling af carbazolyderivater
DK428079A (da) Fremgangsmaade til fremstilling af cyclohexadienderivater
DK150879A (da) Fremgangsmaade til fremstilling af oximderivater af 3-azidomethyl-7-aminothiazolylacetamidocephalosporansyre

Legal Events

Date Code Title Description
PUP Patent expired